Pfizer: Arthritis, Juvenile trials

The registry lists 10 Arthritis, Juvenile studies with Pfizer as lead sponsor. 1 are open to participants now and 7 have results posted.

Phase 1 1Phase 2 1Phase 3 5Phase 4 1No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Korea Xeljanz Post-marketing Surveillance for Juvenile Idiopathic ArthritisRecruitingNCT05754710
• A Safety, Efficacy And Pharmacokinetics Study Of Tofacitinib In Pediatric Patients With sJIACompletedNCT03000439Phase 3Results posted
• Efficacy Study Of Tofacitinib In Pediatric JIA PopulationCompletedNCT02592434Phase 3Results posted
• Pharmacokinetics Of CP-690,550 In Pediatric Patients With Juvenile Idiopathic Arthritis (JIA)CompletedNCT01513902Phase 1Results posted
• Long-Term Safety Study Of Tofacitinib In Patients With Juvenile Idiopathic ArthritisCompletedNCT01500551Phase 2/3Results posted
• Enbrel-Juvenile Idiopathic Arthritis (JIA) Use Results Survey [All-Case Surveillance]CompletedNCT01145352Results posted
• Study Evaluating Etanercept in 3 Subtypes of Childhood ArthritisCompletedNCT00962741Phase 3Results posted
• Study To Determine The Pharmacokinetics Of Sulfasalazine In Children With Juvenile Idiopathic ArthritisTerminatedNCT00637780Phase 4Results posted
• A Study to Evaluate the Efficacy and Safety of Celecoxib Suspension Compared to Naproxen Suspension in Patients With JRACompletedNCT00652925Phase 3
• Study Evaluating the Tolerance and Safety of Enbrel (Etanercept) in Adults and ChildrenCompletedNCT00484809